KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AbbVie (ABBV) Interest Expenses (2016)

Historic Interest Expenses for AbbVie (ABBV) over the last 5 years, with Q2 2016 value amounting to $245.0 million.

  • AbbVie's Interest Expenses rose 4244.19% to $245.0 million in Q2 2016 from the same period last year, while for Mar 2017 it was $245.0 million, marking a year-over-year decrease of 6945.14%. This contributed to the annual value of $719.0 million for FY2015, which is 6759.91% up from last year.
  • AbbVie's Interest Expenses amounted to $245.0 million in Q2 2016, which was up 4244.19% from $215.0 million recorded in Q1 2016.
  • Over the past 5 years, AbbVie's Interest Expenses peaked at $245.0 million during Q2 2016, and registered a low of $10.0 million during Q3 2012.
  • In the last 5 years, AbbVie's Interest Expenses had a median value of $113.0 million in 2012 and averaged $125.8 million.
  • The largest annual percentage gain for AbbVie's Interest Expenses in the last 5 years was 65000.0% (2013), contrasted with its biggest fall of 2127.66% (2013).
  • Over the past 5 years, AbbVie's Interest Expenses (Quarter) stood at $94.0 million in 2012, then fell by 21.28% to $74.0 million in 2013, then soared by 87.84% to $139.0 million in 2014, then surged by 49.64% to $208.0 million in 2015, then increased by 17.79% to $245.0 million in 2016.
  • Its last three reported values are $245.0 million in Q2 2016, $215.0 million for Q1 2016, and $208.0 million during Q4 2015.